Advocacy

ASHP Testifies During Senate Hearing on 340B Drug Pricing Program

Published: March 15, 2018
ASHP News

ASHP reinforced its support for the 340B Drug Pricing Program during March 15 testimony before the Senate Committee on Health, Education, Labor & Pensions. 

Joseph Hill, director of ASHP’s Government Relations Division, emphasized that the program helps maximize scarce federal resources while providing low-income and uninsured patients access to lifesaving medications. Hill’s testimony noted that savings from the 340B program fund critical pharmacist-provided care services such as treatment for opioid abuse, medication management services, and disease management for chronic diseases. Hill also stressed the importance of program compliance and highlighted ASHP’s efforts to ensure that covered entities use the program in a manner consistent with its purpose.

Watch Hill's testimony here.

 

Joseph Hill 340B

ADVERTISEMENT

Posted March 15, 2018
ADVERTISEMENT

Advance Your Professional Development

View All

Medication Safety Certificate


Certification is a process used by health care organizations worldwide to accurately assess their level of performance in relation to established standards and to implement ways to continuously improve.
Enroll Today
New Practitioner Hero Image

Basic in Cardiology Pharmacy Certificate


This self-guided, online learning activity will provide 29 hours of ACPE continuing education for pharmacists, incorporating recorded presentations and skill-focused activities.
Enroll Today
Stories